John C. Cambier

Active 1976–2023

112
Papers
19,066
Citations
88
h-index
112
i10-index

Citations

Citations per year for John C. Cambier1977: 7 citations1979: 6 citations1980: 6 citations1983: 2 citations1984: 7 citations1985: 29 citations1986: 30 citations1987: 70 citations1988: 60 citations1989: 60 citations1990: 53 citations1991: 83 citations1992: 96 citations1993: 110 citations1994: 148 citations1995: 167 citations1996: 206 citations1997: 265 citations1998: 223 citations1999: 214 citations2000: 197 citations2001: 157 citations2002: 189 citations2003: 138 citations2004: 175 citations2005: 110 citations2006: 108 citations2007: 124 citations2008: 111 citations2009: 119 citations2010: 99 citations2011: 98 citations2012: 117 citations2013: 132 citations2014: 99 citations2015: 127 citations2016: 116 citations2017: 151 citations2018: 153 citations2019: 411 citations2020: 414 citations2021: 420 citations2022: 368 citations2023: 278 citations2024: 366 citations2025: 192 citations2026: 8 citations1978: no citations, so this year is not shown1981–1982: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,753 citing papers, 38.5% of this breakdownChina: 811 citing papers, 11.3% of this breakdownGermany: 426 citing papers, 5.9% of this breakdownUnited Kingdom: 420 citing papers, 5.9% of this breakdownFrance: 325 citing papers, 4.5% of this breakdownJapan: 293 citing papers, 4.1% of this breakdownCanada: 275 citing papers, 3.8% of this breakdownAustralia: 198 citing papers, 2.8% of this breakdownItaly: 185 citing papers, 2.6% of this breakdownSwitzerland: 148 citing papers, 2.1% of this breakdownNetherlands: 113 citing papers, 1.6% of this breakdownSpain: 93 citing papers, 1.3% of this breakdown
0%38.5%Other 15.6%

Fields

  • Immunology and Microbiology46.5%
  • Medicine25.7%
  • Biochemistry, Genetics and Molecular Biology24.4%
  • Neuroscience1.4%
  • Agricultural and Biological Sciences0.5%
  • Environmental Science0.3%
  • Other1.2%

Topics

  • T-cell and B-cell Immunology10.1%
  • Immune Cell Function and Interaction9.3%
  • interferon and immune responses5.4%
  • Monoclonal and Polyclonal Antibodies Research4.1%
  • Immunotherapy and Immune Responses3.8%
  • Inflammasome and immune disorders3%
  • Other64.3%

Coauthors

All papers

Open in search
  1. Apoptotic Caspases Suppress mtDNA-Induced STING-Mediated Type I IFN Production

    Authors: , , , , , , , , , , , - Cell 2014 cited by 964

  2. Hypoxia-inducible factor-1 alpha–dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa

    Authors: , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 cited by 553

  3. cGAS drives noncanonical-inflammasome activation in age-related macular degeneration

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , S. Michal Jazwinski, Hiroshi Nagai, Isao Hara, A. Phillip West, Katherine A. Fitzgerald, Srinivas R. Sadda, Bradley D. Gelfand, Jayakrishna Ambati - Nature Medicine 2017 cited by 294

  4. MPYS, a Novel Membrane Tetraspanner, Is Associated with Major Histocompatibility Complex Class II and Mediates Transduction of Apoptotic Signals

    Authors: , , , , , - Molecular and Cellular Biology 2008 cited by 442

  5. MPYS Is Required for IFN Response Factor 3 Activation and Type I IFN Production in the Response of Cultured Phagocytes to Bacterial Second Messengers Cyclic-di-AMP and Cyclic-di-GMP

    Authors: , , , , , , , , - The Journal of Immunology 2011 cited by 282

  6. B cells in type 1 diabetes mellitus and diabetic kidney disease

    Authors: , , - Nature Reviews Nephrology 2017 cited by 153

  7. High-efficiency RNA-based reprogramming of human primary fibroblasts

    Authors: , , , , , , , , , , , , - Nature Communications 2018 cited by 165

  8. Targeting DDR2 enhances tumor response to anti–PD-1 immunotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Science Advances 2019 cited by 127

  9. B Cell Receptor Signal Transduction in the GC Is Short-Circuited by High Phosphatase Activity

    Authors: , , - Science 2012 cited by 287

  10. Tissue distribution and clonal diversity of the T and B cell repertoire in type 1 diabetes

    Authors: , , , , , , , , , , , , , , , , - JCI Insight 2016 cited by 144

  11. B-cell anergy: from transgenic models to naturally occurring anergic B cells?

    Authors: , , , - Nature reviews. Immunology 2007 cited by 341

  12. Of ITIM s, ITAM s, and ITAM is: revisiting immunoglobulin Fc receptor signaling

    Authors: , - Immunological Reviews 2015 cited by 166

  13. Loss of Anergic B Cells in Prediabetic and New-Onset Type 1 Diabetic Patients

    Authors: , , , , , , , , , , - Diabetes 2014 cited by 102

  14. Elevated PTEN expression maintains anergy in human B cells and reveals unexpectedly high repertoire autoreactivity

    Authors: , , , , , , , - JCI Insight 2019 cited by 57

  15. Monophosphorylation of CD79a and CD79b ITAM Motifs Initiates a SHIP-1 Phosphatase-Mediated Inhibitory Signaling Cascade Required for B Cell Anergy

    Authors: , , , , , , , , - Immunity 2011 cited by 165

  16. B cell maintenance and function in aging

    Authors: , , , - Seminars in Immunology 2012 cited by 164

  17. Identification and characterization of a loss-of-function human MPYS variant

    Authors: , , , , , , - Genes and Immunity 2011 cited by 132

  18. Continuous inhibitory signaling by both SHP-1 and SHIP-1 pathways is required to maintain unresponsiveness of anergic B cells

    Authors: , , , , - The Journal of Experimental Medicine 2016 cited by 106

  19. Mast cell–dependent migration of effector CD8+ T cells through production of leukotriene B4

    Authors: , , , , - Nature Immunology 2003 cited by 283

  20. Fcε Receptor I-Associated lyn -Dependent Phosphorylation of Fcγ Receptor IIB During Negative Regulation of Mast Cell Activation

    Authors: , , , , , , - The Journal of Immunology 1998 cited by 161

  21. Endotypes in T1D: B lymphocytes and early onset

    Authors: , , - Current Opinion in Endocrinology Diabetes and Obesity 2020 cited by 27

  22. A partial human LCK defect causes a T cell immunodeficiency with intestinal inflammation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2023 cited by 18

  23. Selective Loss of Responsiveness to Exogenous but Not Endogenous Cyclic-Dinucleotides in Mice Expressing STING-R231H

    Authors: , , , , , , - Frontiers in Immunology 2020 cited by 15

  24. Identification of Anergic B Cells within a Wild-Type Repertoire

    Authors: , , , , , , - Immunity 2006 cited by 274